We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
(-13%)
Cap. Flow
-$699M
Cap. Flow
% of AUM
-18.5%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$28.7M |
| 2 |
Invesco CurrencyShares Euro Currency Trust
FXE
|
+$23.2M |
| 3 |
Biogen
BIIB
|
+$20.8M |
| 4 |
Nike
NKE
|
+$18.3M |
| 5 |
IBM
IBM
|
+$17.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$48.6M |
| 2 |
JPMorgan Chase
JPM
|
+$47.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$46.2M |
| 4 |
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
|
+$31.6M |
| 5 |
Kimco Realty
KIM
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.62% |
| 2 | Industrials | 6.54% |
| 3 | Financials | 6.19% |
| 4 | Technology | 6.15% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABCO
1351
DELISTED
Advisory Board Co
ABCO
| $280K | 0.01% |
+5,651
| New | +$275K |
|
|
ENH
1352
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $280K | 0.01% |
4,379
-13,367
| -75% | -$859K |
|
1353
Citizens Financial Group
CFG
$30.5B
| $279K | 0.01% |
+10,672
| New | +$269K |
|
|
CLR
1354
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $279K | 0.01% |
+12,136
| New | +$388K |
|
1355
Equifax
EFX
$22.1B
| $278K | 0.01% |
2,501
-3,764
| -60% | -$407K |
|
1356
Sony
SONY
$137B
| $278K | 0.01% |
+56,410
| New | +$299K |
|
1357
CALL
Weibo
WB
$1.98B
| $277K | 0.01% |
14,200
| – | – |
|
|
INFO
1358
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $277K | 0.01% |
9,180
+1,675
| +22% | +$49.7K |
|
|
WBMD
1359
DELISTED
WebMD Health Corp.
WBMD
| $277K | 0.01% |
5,745
-2,008
| -26% | -$89.5K |
|
1360
Caleres
CAL
$429M
| $276K | 0.01% |
10,297
+2,833
| +38% | +$82.5K |
|
1361
UnitedHealth
UNH
$386B
| $276K | 0.01% |
2,346
-28,897
| -92% | -$3.38M |
|
|
STI
1362
DELISTED
SunTrust Banks, Inc.
STI
| $276K | 0.01% |
6,437
-61,355
| -91% | -$2.58M |
|
|
NTT
1363
DELISTED
Nippon Telegraph & Telephone
NTT
| $276K | 0.01% |
+6,956
| New | +$263K |
|
1364
Babcock & Wilcox
BW
$1.25B
| $275K | 0.01% |
+1,315
| New | +$240K |
|
1365
Paycom
PAYC
$7.9B
| $275K | 0.01% |
7,319
-21,881
| -75% | -$877K |
|
|
QVCGA
1366
DELISTED
QVC Group Inc Series A
QVCGA
| $275K | 0.01% |
208
-574
| -73% | -$752K |
|
|
STL
1367
DELISTED
Sterling Bancorp
STL
| $275K | 0.01% |
+16,914
| New | +$273K |
|
1368
Energizer
ENR
$1.46B
| $274K | 0.01% |
+8,057
| New | +$308K |
|
1369
Progressive
PGR
$128B
| $274K | 0.01% |
8,617
-4,328
| -33% | -$138K |
|
|
ARI
1370
Apollo Commercial Real Estate
ARI
$873M
| $273K | 0.01% |
+15,835
| New | +$270K |
|
1371
CALL
Element Solutions
ESI
$8.54B
| $273K | 0.01% |
+21,300
| New | +$259K |
|
|
TTM
1372
DELISTED
Tata Motors Limited
TTM
| $273K | 0.01% |
9,264
-1,106
| -11% | -$32.1K |
|
1373
Mueller Water Products
MWA
$3.96B
| $272K | 0.01% |
31,689
-14,025
| -31% | -$122K |
|
1374
CEMIG Preferred Shares
CIG
$6.18B
| $271K | 0.01% |
354,272
-213,546
| -38% | -$197K |
|
|
DF
1375
DELISTED
Dean Foods Company
DF
| $271K | 0.01% |
15,758
-208
| -1% | -$3.75K |
|
Similar funds
PWMG
NIEF
HIM
MCA
OA
MC
CTAF
MWAM
Paloma Partners's Q4 2015 Portfolio in Review
As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.
Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.
- Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
- Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
- Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
- Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
- Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
- Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
- Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.
Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.